Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Петро Тодорович Петрюк, Петр Тодорович ПетрюкfiledCriticalПетро Тодорович Петрюк
Priority to UA95114965ApriorityCriticalpatent/UA22241A/en
Publication of UA22241ApublicationCriticalpatent/UA22241A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The invention relates to the medicine. The method comprises the use of haloperidol and carrying out transcerebral galvanization. The treatment is carried out additionally by “rapid neuroleptisation” method within 30 minutes after morning haloperidol administration, treatment course is 5 days. “Rapid neuroleptisation” is rapid intramuscular haloperidol administration (within 30-60 minutes) at a daily doses from average to high with next transcerebral galvanization by anode current for 20-30 minutes with the gradual increase of current strength from 2 to 5 mA, current density - from 0.04 to 0.08 mA/sm2, 15 daily procedures.
UA95114965A1995-11-221995-11-22Method for treatment of patient with paranoid schizophrenia
UA22241A
(en)
TREATMENT OF MULTIPLE SCLERosis (MS) AND OTHER DEMYELINIZATION DISEASES USING LOFEPRAMINE IN COMBINATION WITH L-PHENYLALAMIN, TYROSINE OR TRYPTOPHAN AND POSSIBLE. A VITAMIN B12 COMPOUND